(ü 1,131) |
|
|
|
|
[] 캴 ȭŰ ܹ S ǥ
9 (FIX) ü ܹ S ǥ ϴ ü ߰ϸ 캴 ȯ ΰ ִ Ҿƿ ȭǴ Ÿ. ̹ PS(ܹ S)
Ȳ
2023-11-29
|
|
|
|
|
[] ȯڴü ҽ '츮' 9,10ȣ
ѱȸ(ȸ û) ȸ ҽ '츮' 9,10ȣ ´.ȸ ȸ ҽİ ȸ ݿ 츮 ϰ ִ.̹ åڿ 4⸸ ȴ ķ ȸ ı ֵ
2023-11-27
|
|
|
|
|
[] ȸ ӿ Ϸ
ѱȸ ȸ 25 ѱ ǿ ӿ ȸ .̳ ӿ ȸ ̳, 縦 8 ȯ ߰, ⸶ ǥ ǥ ƴ.ȸ ĺδ
ϼ
2023-11-27
|
|
|
|
|
|
|
[] ȸ ӿ
ѱȸ ȸ ӿŰ ¾Ҵ.ȸ 11 25 12 30 繫 ȸ ȸ ӿ Ȱ ٷ ϰ ػߴ. յΰ ȸ ֹ̰ ѹ ȸ þ ǥ Ŀ
2023-11-26
|
|
|
|
|
[] ȯ ȸ ̹, ȸ ǥ
ѱȸ ȸ(ȸ 迵) 18() ǿŸ ȸ 迵 ȸ, ϴǿ ȸ ǿ Ǿٰ . ̹ 迵 ȸ ȸ ǿ μ ǥ
Ȳ
2023-11-24
|
|
|
|
|
[] 泲ȸ, ȣ ȸ ...ǿ û
캴 ȯڴü ѱȸ λ泲ȸ 12 Ͽ λǿ α Ĵ翡 ӿ(ȸ, ǿ) ȸ .̳ ӿ û ȸ 17 ȯ ߰, ǥ Ļ ƴ.
±
2023-11-24
|
|
|
|
|
[] 캴 ġ ġ ɽƮó
() μ DZⰡ ӻ ߿ ϰ ִ. ŸDZ ؾ ϸ, Ʈ ʸ ̷ ־ ϰ, ÷Ʈ, Ŭ ε Ƹ ־ Ѵ. ̷
Ȳ
2023-11-24
|
|
|
|
|
[] ߱ 캴 ġ, ߰
ֱ ġ ִ (Gritgen Therapeutics) ο ִ ġ GS1191 ߱ ұԸ ӻ迡 캴A ȯ (FVIII) Ȱȭ
Ȳ
2023-11-22
|
|
|
|
|
[] 泲ȸ ' '
泲ȸ 11 11 뺴 ȸǽǿ ȸ 2024 ȸ ̲ ȸ ǿ ߴ.ӱ 3 ȸδ 泲ȸ ûȸ â(33) 缱Ǿ, ӱ 2 ǿδ
2023-11-22
|
|
|
|
|
[] ȸ ӿ
캴 ȯڴü ѱȸ ȸ 11, 5ð 뱸 ġ Ϳ 2024 ȸ ӿ ȸ ǽߴ.̳ 13 ȯ 繫 û ȸ Ͽ Ÿ տȣ
ϼ
2023-11-22
|
|
|
|
|
[] ȸ ¶ǥ 6ð ǥ 50% Ѿ
캴 ȯڴü ѱȸ ȸ 2024 ӿ ¶ǥ ǥ ǥ ù 50% Ѿ.ȸ 2024 ۵Ǵ ӱ ȸ(3) ǿ(2) ̴ Ÿ Կ ־ 11 25 ǥ,
2023-11-20
|
|
|
|
|
[WFH 2024 LIVE] WFH, 2024
쿬(World Federation of Hemophilia) Ȩ 2024 ̿ ȸ: ȯ ˱⡯ 縦 ̶ . WFH ο ġ
Ȳ
2023-11-17
|
|
|
|
|
[] Ÿ, ο EU AAV5 ü Ʈ
캴A ġ Ÿ(Roctavian, valoctocogene roxaparvovec-rvox) ü ȯ ġῡ ݼ ϴµ Ǵ Ʈ AAV5 DetectCDx (EU)
Ȳ
2023-11-17
|
|
|
|
|
[] WFH, 2022 ۷ι ǥ
WFH Ȩ 2022 ۷ι (Annual Global Survey, AGS) Ͽٰ . ۷ι WFH 'θ ġ' ǥ ϴ
Ȳ
2023-11-16
|
|
|
|
|
[] Ʈ 뺸ũ, 캴A ġḦ
Ʈ ̾(Genevant Sciences) 뺸ũ(Novo Nordisk) Ͽ Ʈ (lipid nanoparticle, LNP) ÷ ÷ mRNA megaTAL 캴A
Ȳ
2023-11-16
|
|
|
|
|
[ Inside] ö " 캴A 80 60 ֻ "
캴 ö ' 캴 κ ( Ȱ 5%~40%) · '̶ ߴ. 4~5 ÿ 캴 ȯڴü ѱȸ ûũ 뺴 Ҿûҳ ö
2023-11-15
|
|
|
|
|
[] SerpinPC, 캴B üȯڿ ù ӻ
(Centessa Pharmaceuticals) ȸ ǥڷḦ SerpinPC ȿ ϴ 2b ӻ迡 ü ִ ù° ڰ Ҵٰ ߴ. ߺι ְ ̹(Ant
Ȳ
2023-11-15
|
|
|
|
|
[ Inside] ȿö "캴 ġ ̱ ð ־"
̱ 캴 ġ ʰ ϳ ð ִ Ȯεǰ ִ. 10 13 ҳ縮ü ǿ 11ȸ ȸ 캴ȸ(ȸ ) ȿö (ȿö̻Ƴ) ̱ ȯ
2023-11-10
|
|
|
|
|
[] ij, 캴B ġ 'н'
ij Ǻδ ϰų ̱ ϻ ϴ 캴B ȯڸ ġϱ ġ ɼ ġ н(Hemgenix, etranacogene dezaparvovec) ߴٰ ǥߴ.
Ȳ
2023-11-09
|
|
|